Diaceutics 

$2.00
10
+$0.00+0% Thursday 13:30

Statistics

Day High
2
Day Low
2
52W High
2
52W Low
1.3672
Volume
3,500
Avg. Volume
-
Mkt Cap
169.63M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26MayExpected
Q1 2024
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
-3.65
-0.93
1.78
4.5
Expected EPS
2.9534167136000002
Actual EPS
2.9534167136000002

Financials

-5.33%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
80.67MRevenue
-4.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DIUXF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Diaceutics PLC operates as a global diagnostic commercialization entity, providing pharmaceutical companies worldwide with essential data, sophisticated analytics, and implementation support. Central to its offerings is the DXRX platform, a comprehensive suite designed to address various aspects of precision medicine. This platform delivers: DXRX Data Solutions: Granting access to a vast network of laboratory diagnostic testing data. Key components here include DXRX Signal (for specific data insights), Lab Mapping, a Testing Dashboard, and Physician Mapping services. DXRX Marketplace Solutions: A crucial hub that fosters collaborations between laboratories, pharmaceutical firms, and diagnostic companies to advance precision medicine initiatives. DXRX Patient Journey: Enables pharmaceutical clients to conduct in-depth, longitudinal analyses of individual patient biomarker testing pathways. This insight is vital for pinpointing opportunities for earlier intervention and optimized treatment strategies. DXRX Lab Benchmarking: Empowers laboratories to enhance their competitive standing by comparing critical performance metrics – such as disease profiles, testing methodologies, market share, and turnaround times – against industry peers. DXRX Test Reimbursement: Facilitates pharmaceutical companies' engagement with laboratories to secure funding for the launch of novel companion diagnostics, thereby accelerating test adoption and market penetration. DXRX Test Signal: Provides real-time alerts regarding testing events, enabling pharmaceutical clients to quickly identify patients who may benefit from specific therapies. Beyond the DXRX platform, Diaceutics offers a range of supplementary services. These include strategic consulting for precision medicine diagnostics, as well as diagnostic landscape analysis, planning, implementation, and tracking. The company also provides support for test standardization, quality assessment, report optimization, laboratory technical assistance, test access and reimbursement solutions, comprehensive laboratory training, and educational resources. Established in 2005, Diaceutics PLC maintains its headquarters in Belfast, United Kingdom.
Show more...
CEO
Mr. Peter Keeling
Employees
184
Country
Ireland
ISIN
GB00BJQTGV64

Listings

0 Comments

Share your thoughts

FAQ

What is Diaceutics stock price today?
The current price of DIUXF is $2.00 USD — it has increased by +0% in the past 24 hours. Watch Diaceutics stock price performance more closely on the chart.
What is Diaceutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Diaceutics stocks are traded under the ticker DIUXF.
Is Diaceutics stock price growing?
DIUXF stock has risen by +0% compared to the previous week, the month change is a +19.76% rise, over the last year Diaceutics has showed a +46.28% increase.
What is Diaceutics market cap?
Today Diaceutics has the market capitalization of 169.63M
When is the next Diaceutics earnings date?
Diaceutics is going to release the next earnings report on September 29, 2026.
What were Diaceutics earnings last quarter?
DIUXF earnings for the last quarter are 0.04 USD per share, whereas the estimation was 0.04 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Diaceutics revenue for the last year?
Diaceutics revenue for the last year amounts to 80.67M USD.
What is Diaceutics net income for the last year?
DIUXF net income for the last year is -4.3M USD.
How many employees does Diaceutics have?
As of June 11, 2026, the company has 184 employees.
In which sector is Diaceutics located?
Diaceutics operates in the Health & Wellness sector.
When did Diaceutics complete a stock split?
Diaceutics has not had any recent stock splits.
Where is Diaceutics headquartered?
Diaceutics is headquartered in Belfast, Ireland.